节点文献

佳林豪(重组人促红细胞生成素)治疗肾性贫血临床观察

Observation on Therapeutic Effect of Jialinhao-recombinant Human Erythropoietin on Anemia in Patients with Renal Chronic Failure

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王庆芳

【Author】 WANG Qing-fang(Zaozhuang Municipal Hospital,Shandong Zaozhuang 277100,China)

【机构】 山东省枣庄市立医院肾内科 山东枣庄277100

【摘要】 目的:观察佳林豪(重组人促红细胞生成素rHuEPO)治疗肾性贫血的疗效及不良反应。方法:39例肾性贫血患者皮下注射佳林豪,疗程12周,采用自身对照法观察临床治疗后情况。结果:显效25例,有效12例,总有效率为94.87%,不良反应有血压升高、注射部位疼痛,非透析治疗患者用药期间未见明显肾功能恶化。结论:佳林豪冶疗肾性贫血安全、有效。

【Abstract】 Objective: To observe the effects and side effects of Jialinhao-recombinant human erythropoietin(rHuEPO) on patients with anemia in chronic renal failure(CRF).Method: 39 patients with anemia in CRF had been given Jialinhao by subcutaneous injection for 12 weeks,the clinical effects were observed by own control method.Result: Excellence cases amounted 25,efficacy cases 12,and the overall efficacy rate was 94.87 %;The side effects included hypertension,pain in injection site.No degradation in renal function was found in non-dialysis patients during the medication.Conclusion: JIALINHAO could improve anemia in CRF safely and effectively.

【关键词】 肾性贫血佳林豪疗效
【Key words】 Anemia in chronic renal failureJialinhaoClinical effect
  • 【分类号】R692.5
  • 【被引频次】2
  • 【下载频次】59
节点文献中: 

本文链接的文献网络图示:

本文的引文网络